Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Witold Ruzyllo

Showing results (101-110 of 106) with videos related to

Pageof 11
Sort By:
You have reached the last page of results.This site can display upto 106 results.
Circulation|May 4, 2013
Efficacy and safety of apixaban compared with warfarin at different levels of predicted international normalized ratio control for stroke prevention in atrial fibrillationLars Wallentin, Renato D Lopes, Michael Hanna, et al.
JAMA|July 9, 2004
Enoxaparin vs unfractionated heparin in high-risk patients with non-ST-segment elevation acute coronary syndromes managed with an intended early invasive strategy: primary results of the SYNERGY randomized trialJames J Ferguson, Robert M Califf, Elliott M Antman, et al.
JAMA|September 3, 2013
Anticoagulation with otamixaban and ischemic events in non-ST-segment elevation acute coronary syndromes: the TAO randomized clinical trialPhilippe Gabriel Steg, Shamir R Mehta, Charles V Pollack, et al.
The New England Journal of Medicine|August 28, 2012
Prasugrel versus clopidogrel for acute coronary syndromes without revascularizationMatthew T Roe, Paul W Armstrong, Keith A A Fox, et al.
The New England Journal of Medicine|November 15, 2011
Thrombin-receptor antagonist vorapaxar in acute coronary syndromesPierluigi Tricoci, Zhen Huang, Claes Held, et al.
The New England Journal of Medicine|April 1, 2020
Initial Invasive or Conservative Strategy for Stable Coronary DiseaseDavid J Maron, Judith S Hochman, Harmony R Reynolds, et al.
Pageof 11

Showing results (101-110 of 106) with videos related to

Sort By:
Pageof 11
You have reached the last page of results.This site can display upto 106 results.
Circulation|May 4, 2013
Efficacy and safety of apixaban compared with warfarin at different levels of predicted international normalized ratio control for stroke prevention in atrial fibrillationLars Wallentin, Renato D Lopes, Michael Hanna, et al.
JAMA|July 9, 2004
Enoxaparin vs unfractionated heparin in high-risk patients with non-ST-segment elevation acute coronary syndromes managed with an intended early invasive strategy: primary results of the SYNERGY randomized trialJames J Ferguson, Robert M Califf, Elliott M Antman, et al.
JAMA|September 3, 2013
Anticoagulation with otamixaban and ischemic events in non-ST-segment elevation acute coronary syndromes: the TAO randomized clinical trialPhilippe Gabriel Steg, Shamir R Mehta, Charles V Pollack, et al.
The New England Journal of Medicine|August 28, 2012
Prasugrel versus clopidogrel for acute coronary syndromes without revascularizationMatthew T Roe, Paul W Armstrong, Keith A A Fox, et al.
The New England Journal of Medicine|November 15, 2011
Thrombin-receptor antagonist vorapaxar in acute coronary syndromesPierluigi Tricoci, Zhen Huang, Claes Held, et al.
The New England Journal of Medicine|April 1, 2020
Initial Invasive or Conservative Strategy for Stable Coronary DiseaseDavid J Maron, Judith S Hochman, Harmony R Reynolds, et al.
Pageof 11